| Oct 9 |
Viking Therapeutics Reveals Encouraging Data From Genetic Disorder Drug Study, Analyst Says Focus On Orphan Disease Broadens Viking's Potential Revenue Streams
|
| Oct 9 |
Viking Therapeutics Announces Results from Phase 1b Clinical Trial of VK0214 in Patients with X-ALD
|
| Oct 7 |
Viking Therapeutics, Inc. (VKTX): A Hot Stock to Buy Now
|
| Oct 7 |
2 Soaring Stocks That Could Climb Another 112% and 120%, According to Wall Street Analysts
|
| Oct 4 |
Viking Therapeutics, Inc. (VKTX) Rises Higher Than Market: Key Facts
|
| Oct 4 |
As Weight-Loss Drugs Battle, Upstart Viking Therapeutics Threatens Eli Lilly, Novo Nordisk, Pfizer
|
| Oct 2 |
Weight loss drug breakthroughs, gene therapies, and more: 8 clinical trials to watch right now
|
| Sep 30 |
Why Viking Therapeutics Stock Topped the Market Today
|
| Sep 29 |
Is Viking Therapeutics Stock a Buy?
|
| Sep 29 |
Is Viking Therapeutics, Inc. (VKTX) the Best Performing Long Term Stock in 2024?
|
